دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Demystifying Disability Assessments for Dermatologists—A Call to Action
Jessica Dawson, MD1; Jan Smogorzewski, MD1
doi : 10.1001/jamadermatol.2021.1767
JAMA Dermatol. 2021;157(8):903-904
Equity and the JAMA Network
Phil B. Fontanarosa, MD, MBA1; Annette Flanagin, RN, MA2; John Z. Ayanian, MD, MPP3,4; Robert O. Bonow, MD, MS5,6; Neil M. Bressler, MD7,8; Dimitri Christakis, MD, MPH9,10; Mary L. Disis, MD11,12; S. Andrew Josephson, MD13,14; Melina R. Kibbe, MD15,16; Dost Öngür, MD, PhD17,18; Jay F. Piccirillo, MD19,20; Rita F. Redberg, MD, MPH21,22; Frederick P. Rivara, MD, MPH23,24; Kanade Shinkai, MD, PhD25,26; Clyde W. Yancy, MD, MSc27,28
doi : 10.1001/jamadermatol.2021.2443
JAMA Dermatol. 2021;157(8):905-907
History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease
Takashi Hashimoto, MD1; Jun Yamagami, MD, PhD2; John J. Zone, MD3
doi : 10.1001/jamadermatol.2021.0761
JAMA Dermatol. 2021;157(8):907-909
A Staphylococcus Path to Improved Therapeutics in Atopic Dermatitis
Tamia A. Harris-Tryon, MD, PhD1,2; Shai Bel, PhD3
doi : 10.1001/jamadermatol.2021.1310
JAMA Dermatol. 2021;157(8):909-910
Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita
Mareike Becker, MD1,2; Nina Schumacher, MD1; Enno Schmidt, MD, PhD1,2,3; Detlef Zillikens, MD1,3; Christian D. Sadik, MD1,3
doi : 10.1001/jamadermatol.2021.0762
JAMA Dermatol. 2021;157(8):917-923
Immunoglobulin A (IgA) epidermolysis bullosa acquisita (EBA) is an autoimmune skin blistering disease with IgA autoantibodies directed against type VII collagen. There is debate whether it should be considered part of the clinical spectrum of linear IgA bullous dermatosis (LABD) or a separate disease entity.
Prevalence of Hidradenitis Suppurativa
Abdulhadi Jfri, MD, MSc1; David Nassim, BSc2; Elizabeth O’Brien, MD1; Wayne Gulliver, MD3; Georgios Nikolakis, MD4,5; Christos C. Zouboulis, MD, PhD4,5
doi : 10.1001/jamadermatol.2021.1677
JAMA Dermatol. 2021;157(8):924-931
Hidradenitis suppurativa/acne inversa (HS) is a chronic inflammatory skin disease characterized by occlusion of hair follicles as a primary pathogenic factor. There are scarce data regarding the prevalence of HS.
Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE Syndrome
Colleen H. Cotton, MD1,2; Jusleen Ahluwalia, MD3; Daniel M. Balkin, MD, PhD4; Ilona J. Frieden, MD5; Anita N. Haggstrom, MD6; Leslie A. Castelo-Soccio, MD, PhD7; Carmen Liy-Wong, MD8; Elena Pope, MD, MSc8; Jack E. Steiner, MD9; Dawn H. Siegel, MD9; Esteban Fernandez-Faith, MD10; Kimberly D. Morel, MD11,12; Christine T. Lauren, MD11,12; Maria C. Garzon, MD11,12; Anthony J. Mancini, MD13; Sarah L. Chamlin, MD13; Megha M. Tollefson, MD14,15; Marilyn G. Liang, MD16; Sophia Delano, MD16; Sharon A. Glick, MD17; Marcia Hogeling, MD18; Victoria R. Barrio, MD19; and the PHACE Retrospective Study Group
doi : 10.1001/jamadermatol.2021.1901
JAMA Dermatol. 2021;157(8):932-939
A 2010 prospective study of 108 infants estimated the incidence of PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome to be 31% in children with facial infantile hemangiomas (IHs) of at least 22 cm2. There is little evidence regarding the associations among IH characteristics, demographic characteristics, and risk of PHACE syndrome.
Psoriasis Prevalence in Adults in the United States
April W. Armstrong, MD, MPH1; Manan D. Mehta, BS1; Clayton W. Schupp, PhD2; George C. Gondo, MA3; Stacie J. Bell, PhD3; Christopher E. M. Griffiths, MD4
doi : 10.1001/jamadermatol.2021.2007
JAMA Dermatol. 2021;157(8):940-946
Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease.
Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic
Patrick E. McCleskey, MD1; Bree Zimmerman, MD1,2; Amara Lieberman, MD1; Liyan Liu, MD, MSc3; Cynthia Chen, MD1; Farzam Gorouhi, MD1; Christine C. Jacobson, MD1; David S. Lee, MD1; Achyuth Sriram, MD2; Amanda Thornton, MD4; Arnd M. Herz, MD2,4; Paradi Mirmirani, MD1; Lisa J. Herrinton, PhD3
doi : 10.1001/jamadermatol.2021.2120
JAMA Dermatol. 2021;157(8):947-953
Beginning in March 2020, case reports and case series linked the COVID-19 pandemic with an increased occurrence of chilblains, but this association has not been evaluated in an epidemiologic study.
T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
Jennifer A. Marks, MD1; Jeffrey M. Switchenko, PhD2; Dylan J. Martini, MD1; Erica S. Tarabadkar, MD3; Mohammad K. Khan, MD, PhD4; Mary Jo Lechowicz, MD5; Pamela B. Allen, MD5
doi : 10.1001/jamadermatol.2021.2191
JAMA Dermatol. 2021;157(8):954-962
The prognostic significance of clonal T-cell receptor (TCR) rearrangement or low-level blood involvement as assessed by flow cytometry for patients with early-stage cutaneous T-cell lymphoma (CTCL) is not clear.
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia
Chun-Hsien Huang, MD1; Yun Fu, MD1; Ching-Chi Chi, MD, MMS, DPhil1,2
doi : 10.1001/jamadermatol.2021.2196
JAMA Dermatol. 2021;157(8):963-970
Androgenetic alopecia (AGA) is associated with trichodynia, anxiety, low self-esteem, and depression, which have implications for quality of life. However, no systematic evaluation has been performed on the association of AGA with health-related quality of life (HRQOL).
Limitations of Using Questionnaires for Assessing the Prevalence of Psoriasis and Atopic Dermatitis Among Adults
Lea K. Nymand, MSc1; Yuki M. F. Andersen, MD, PhD1; Jacob P. Thyssen, MD, PhD, DMSc1; Alexander Egeberg, MD, PhD1
doi : 10.1001/jamadermatol.2021.2307
JAMA Dermatol. 2021;157(8):971-977
Questionnaire studies are important for estimating the prevalence of psoriasis and atopic dermatitis; however, validity among the adult population remains an important concern.
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis
Teruaki Nakatsuji, PhD1; Richard L. Gallo, MD, PhD1; Faiza Shafiq, MBBS1; Yun Tong, MD1; Kimberly Chun, MD1; Anna M. Butcher, BS1; Joyce Y. Cheng, MD1; Tissa R. Hata, MD1
doi : 10.1001/jamadermatol.2021.1311
JAMA Dermatol. 2021;157(8):978-982
Atopic dermatitis (AD) can be negatively affected by Staphylococcus aureus. The skin microbiome of AD is deficient in coagulase-negative Staphylococcus (CoNS) that can kill S aureus.
Trends of Research Output of Allopathic Medical Students Matching Into Dermatology, 2007-2018
Jatin Narang, BS1; Anna Eversman, BS2; Mehak Kalra, BA2; Frederick Morgan, BSPH1; Elizabeth Obi, BA2; Emma R. Russell, BA2; Angela H. Wei, BS1; David X. Zheng, BA2; Wilhemina Osei-Koomson, MPhil1; Amy S. Nowacki, PhD3; Bryan T. Carroll, MD, PhD2,4; Timmie R. Sharma, MD2,4
doi : 10.1001/jamadermatol.2021.2000
JAMA Dermatol. 2021;157(8):983-987
According to the National Residency Matching Program’s biennial Charting Outcomes in the Match (NRMP ChOM) reports, the mean number of research items of matched allopathic dermatology applicants has nearly tripled since 2007, rising from 5.7 to 14.7. Research items are self-reported by applicants and serve as an approximation of research output. Because the NRMP research items field is unverified and reported as an aggregate of several different research pursuits, it may not be an accurate representation of applicant research output.
Cutaneous Vasculitis in Systemic Lupus Erythematosus
Lu Yang, MD1; Yue-Ping Zeng, MD1
doi : 10.1001/jamadermatol.2021.1917
JAMA Dermatol. 2021;157(8):991
Minocycline-Induced Hyperpigmentation
Patrick Wang, BHSc1; James P. Farmer, MD1; Jacob Rullo, MD, PhD1
doi : 10.1001/jamadermatol.2021.2211
JAMA Dermatol. 2021;157(8):992
Painful Palmar and Plantar Purpura
Yoshihito Minami, MD1,2; Youichi Ogawa, MD, PhD1; Katsuhiko Tsukamoto, MD, PhD2
doi : 10.1001/jamadermatol.2021.1792
JAMA Dermatol. 2021;157(8):993-994
Chronic, Scaly, Hypopigmented Macules on the Face
Rachel L. Flint, MS1; Caleb Hixson, DO2; Kristina Burke, MD3
doi : 10.1001/jamadermatol.2021.2466
JAMA Dermatol. 2021;157(8):995-996
Association of Neuropathic Itch With Patients’ Quality of Life
Zoe M. Lipman, BS1; Qai Ven Yap, BS2; Leigh Nattkemper, PhD1; Gil Yosipovitch, MD1
doi : 10.1001/jamadermatol.2021.2010
JAMA Dermatol. 2021;157(8):997-998
Punctate Anetoderma After Colony-Stimulating Factor 1 Receptor and Programmed Cell Death 1 Blockade With Irradiation
Julia Dai, MD1; Yuanyuan Zha, PhD2; Corey C. Foster, MD, MS3; Jason J. Luke, MD4; Steven J. Chmura, MD, PhD5; Mark D. Hoffman, MD1
doi : 10.1001/jamadermatol.2021.2049
JAMA Dermatol. 2021;157(8):998-1000
Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines
Lacey B. Robinson, MD, MPH1; Xiaoqing Fu, MS1; Dean Hashimoto, MD2; Paige Wickner, MD, MPH3; Erica S. Shenoy, MD, PhD1; Adam B. Landman, MD3; Kimberly G. Blumenthal, MD, MSc1
doi : 10.1001/jamadermatol.2021.2114
JAMA Dermatol. 2021;157(8):1000-1002
Treatment of Posttraumatic Reactive Angioendotheliomatosis With Topical Timolol Maleate
Riti Bhatia, MD1; Neirita Hazarika, MD1; Divya Chandrasekaran, MD1; Vishal Gupta, MD2; Prashant Durgapal, MD3; Sanjeev Kishore, MD3
doi : 10.1001/jamadermatol.2021.1770
JAMA Dermatol. 2021;157(8):1002-1004
Complete Remission of Basal Cell Carcinoma Following Treatment With Cemiplimab After 2 Years
Konstantin Dumann, MD1; Niklas Artz1; Mirjana Ziemer, MD1
doi : 10.1001/jamadermatol.2021.2206
JAMA Dermatol. 2021;157(8):1004-1006
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied
Mark C. Mochel, MD1; David E. Elder, MB, ChB2
doi : 10.1001/jamadermatol.2021.2137
JAMA Dermatol. 2021;157(8):1006
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied—Reply
Richard A. Scolyer, MD1,2,3; Mary-Ann El Sharouni, MD1,4; John F. Thompson, MD1,2,5
doi : 10.1001/jamadermatol.2021.1497
JAMA Dermatol. 2021;157(8):1006-1007
Notice of Retraction. Yousaf A et al. Association Between Alopecia Areata and Natural Hair Color Among White Individuals. JAMA Dermatol. Published Online March 10, 2021.
Ahmed Yousaf, BA1; Justin Lee, BS1; Wei Fang, PhD2; Michael S. Kolodney, MD, PhD1
doi : 10.1001/jamadermatol.2021.1832
JAMA Dermatol. 2021;157(8):1007-1008
